I would assume that if an entity "abandons" a trademark, that it falls back to the public domain, at which point a different entity can apply to register it. I assume it might become available for re-registration by another entity even faster if there has been no statement of use filed (no chance of consumers being confused). But these are all complete assumptions on my part.Quote:The current federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED.
If that's the case, though, then maybe CytoDyn did a search of available drug-related names that contained anything relating to "Immuno", and decided to use Immuvance.
I'm not much of a fan of most drug names, they are hard for consumers to pronounce, and they rarely sound anything like the conditions they treat.
I can't say Immuvance rings any bells for me either. I get the "Immu" part -- and I suppose "vance" is a subset of "advance" or "advanced" to someone in a board room. But if I had a drug that could treat a broad swath of diseases, I'm not sure I would have gone in that direction.